A randomized phase II study of TSU-68 in patients (pts) with hepatocellatar carcinoma (HCC) treated by transarterial cheinoembolizabon (TACE)

被引：5

作者：

Arai, Y.

Inaba, Y.

Yamamoto, T.

Kanai, F.

Aramaki, T.

Tanaka, T.

Yamakado, K.

Kudo, M.

Kaneko, S.

Imanaka, K.

机构：

[1] Natl Canc Ctr, Tokyo, Japan

[2] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan

[3] Tochigi Canc Ctr, Utsunomiya, Tochigi, Japan

[4] Chiba Univ Hosp, Chiba, Japan

[5] Shizuoka Canc Ctr, Shizuoka, Japan

[6] Nara Med Univ Hosp, Nara, Japan

[7] Mie Univ Hosp, Tsu, Mie, Japan

[8] Kinki Univ, Sch Med, Osaka 589, Japan

[9] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan

[10] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.4030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4030

引用

页数：1